Hydroxy pioglitazone (M-IV)
CAS: 146062-44-4
Ref. 3D-FH24088
| 1mg | 996.00 € | ||
| 2mg | 1,339.00 € | ||
| 5mg | 1,607.00 € | ||
| 250µg | 420.00 € | ||
| 500µg | 598.00 € |
Product Information
- 5-[[4-[2-[5-(1-Hydroxyethyl)-2-pyridinyl]ethoxy]phenyl]methyl]-2,4-thiazolidinedione
- 5-[[4-[2-[5-(1-Hydroxyethyl)-2-Pyridinyl]Ethoxy] Phenyl]Methyl]-2,4-Thiazolidinedione
- Hydroxy Pioglitazone (M-IV)
- Pioglitazone, hydroxy M-IV
- 5-(4-{2-[5-(1-Hydroxyethyl)Pyridin-2-Yl]Ethoxy}Benzyl)-1,3-Thiazolidine-2,4-Dione
Hydroxy pioglitazone (M-IV) is a derivative of the antidiabetic agent pioglitazone. It is a hydroxy derivative that has been shown to inhibit mitochondrial fatty acid synthesis and increase mitochondrial membrane potential. This drug also inhibits the activity of enzymes involved in fatty acid synthesis, including the enzyme acetyl coenzyme A carboxylase, thereby reducing the production of fatty acids. The hydroxy derivative of pioglitazone has been shown to have an improved pharmacokinetic profile when compared with its parent compound.
Chemical properties
Technical inquiry about: 3D-FH24088 Hydroxy pioglitazone (M-IV)
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
